# Intravenous Lidocaine in Bariatric Surgery.

> **NCT03211455** · PHASE3 · COMPLETED · sponsor: **University Hospital, Caen** · enrollment: 180 (actual)

## Conditions studied

- Morbid Obesity
- Bariatric Surgery Candidate

## Interventions

- **DRUG:** Lidocaine
- **DRUG:** isotonic saline

## Key facts

- **NCT ID:** NCT03211455
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-01
- **Primary completion:** 2019-02-01
- **Final completion:** 2019-05-01
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2026-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03211455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03211455, "Intravenous Lidocaine in Bariatric Surgery.". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03211455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*